The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Is Genome Sequencing Surpassing Medical Knowledge?

October 29, 2010 1:37 pm | Podcasts | Comments

The cost of sequencing a human genome is plummeting, and soon many people may obtain a copy of their own. But how useful is that information to patients, especially if their genes predict untreatable, fatal diseases? Hank Greely discusses the promise and the pitfalls of genetic testing.

The Mysterious Life Of The Cholera Bacterium

October 29, 2010 1:37 pm | Podcasts | Comments

Scientists have long known that cholera is caused by a bacterium transmitted through food or water. But where does the bacterium live between epidemics, and what dictates the timing of new outbreaks? CDC cholera expert Eric Mintz discusses the bacterium behind the Haiti outbreak.

'Goat Sucker' May Just Be A Mangy Coyote

October 29, 2010 1:37 pm | Podcasts | Comments

The legend of the ferocious chupacabra, or goat sucker, has circulated around Central America since the 1990s. But the supernatural chimeric beast -- described by some as half dog, half bat -- may just be a coyote suffering from mange, says entomologist Barry OConnor of the University of Michigan.


The Past, Locked In Amber

October 29, 2010 1:37 pm | Podcasts | Comments

Scientists excavating an Indian amber deposit say it dates back more than 50 million years, and contains the remains of at least 100 previously undocumented species of insects. American Museum of Natural History curator David Grimaldi describes the amber, and the organisms trapped within it.

Zebrafish yield clues to how we process visual information

October 29, 2010 1:35 pm | by Lawrence Berkeley National Laboratory | News | Comments

To a hungry fish on the prowl, the split-second neural processing required to see and gobble up prey is a matter of survival. To scientists, it’s a window into how our brain coordinates eye motions that enable us make our way in a world full of danger and opportunity. This process is now...


Heparin Sodium (B. Braun): Recall - Trace Contaminant

October 29, 2010 1:31 pm | by U.S. Food & Drug Administration | News | Comments

Oversulfated chondroitin sulfate (OSCS) contaminant found during sample testing.


Roche Introduces Immunoassay Module for cobas® 8000 Modular Analyzer Series In U.S.

October 29, 2010 10:31 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Oct. 29 /- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas® 8000 modular analyzer series for diagnostic labs with high-volume workloads. Labs will now be able to combine this new...


Methotrexate Injection, 50mg/2mL and 250mg/10mL Vials: Recall - Presence of Glass Particulates

October 29, 2010 9:35 am | by U.S. Food & Drug Administration | News | Comments

Potential to develop adverse reactions in areas where the particles lodge, which could result in serious adverse events, disability, or death.


ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences

October 29, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

EXTON, Pa., Oct. 29 /- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that William Roberts, vice president, corporate communications of ViroPharma, will present at the Oppenheimer 21st Annual Healthcare Conference at 3:55 P.M. ET on Tuesday, November 2, 2010.  The conference...


Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R & D Alliance

October 29, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Oct. 29 /- Covance Inc (NYSE: CVD ) today announced that it has closed its transactions with sanofi-aventis to become its R&D partner over the next 10 years and to purchase sanofi-aventis' Porcheville, France and Alnwick, United Kingdom sites.  Covance has...


Neighborhood House, Health Center Team Up

October 29, 2010 9:33 am | by San Diego Business Journal | News | Comments

Two San Diego community organizations are joining forces to enhance health care assistance to 8,000 San Diego County preschool children.


Lilly CEO: 'Are We Getting Our Money's Worth from Medical Innovation?'

October 29, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

DALLAS, Oct. 29 /- In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company (NYSE: LLY ), said that the value of medical innovation – particularly innovative medicines – far outstrips its cost....


VIDEO from and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer

October 29, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 29 /- See video from Roche Pharmaceuticals at: Roche announced on October 29 that the European Commission has...


New report underlines the threat to universal access to HIV prevention, treatment and care due to a slow-down in treatment scale-up and waning political will

October 29, 2010 8:35 am | by EurekAlert | News | Comments

(International AIDS Society) A report issued today by the International AIDS Society, Universal Access: Right Here, Right Now documents the principal debates around universal access during the XVIII International AIDS Conference (AIDS 2010). The report also takes stock of progress...


Henry Schein 3Q profit falls on costs

October 29, 2010 7:45 am | by The Associated Press | News | Comments

Medical device and services distributor Henry Schein Inc. said Thursday its third-quarter profit fell 9 percent on higher costs and a boost in tax expenses.The company reported net income of $87.9 million, or 94 cents per share, for the three months ended Sept. 25, down from $96.4 million, or...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.